Association of Helicobacter pylori with elevated blood ammonia levels in cirrhotic patients: A meta-analysis

Yonsei Medical Journal

Volumn 54, Issue 4, 2013, Pages 832-838

  Jiang, Hai Xing ^a   Qin, Shan Yu ^a   Min, Zhi Gang ^b   Xie, Ming Zhi ^a   Lin, Tao ^a   Hu, Bang Li ^c   Guo, Xiao Yun ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b YIXING PEOPLE S HOSPITAL   (China)

^c Guangxi Science and Technology Information Research Institute   (China)

Author keywords

Ammonia; Blood; Helicobacter pylori; Meta analysis

Indexed keywords

AMMONIA BLOOD LEVEL; ARTICLE; ASIAN; DISEASE ASSOCIATION; HELICOBACTER INFECTION; HUMAN; LIVER CIRRHOSIS; META ANALYSIS; NONHUMAN; PUBLISHING; QUALITY CONTROL; SENSITIVITY ANALYSIS;

AMMONIA; BLOOD; HELICOBACTER PYLORI; META-ANALYSIS;

AMMONIA; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIVER CIRRHOSIS; PUBLICATION BIAS; REGRESSION ANALYSIS;

EID: 84878255245     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2013.54.4.832     Document Type: Article

References (35)

1. Souba WW. Interorgan ammonia metabolism in health and disease: a surgeon's view. JPEN J Parenter Enteral Nutr 1987;11:569-79.
2. LeVeen HH, LeVeen EG, LeVeen RF. Awakenings to the pathogenicity of urease and the requirement for continuous long term therapy. Biomed Pharmacother 1994;48:157-66.
3. Demirtürk L, Yazgan Y, zci O, Ozel M, Toǧrol E, Gültepe M, et al. The effect of Helicobacter pylori eradication on gastric juice and blood ammonia concentrations and on visual evoked potentials in cirrhotics. Helicobacter 2001;6:325-30.
4. Queiroz DM, Rocha AM, Rocha GA, Cinque SM, Oliveira AG, Godoy A, et al. Association between Helicobacter pylori infection and cirrhosis in patients with chronic hepatitis C virus. Dig Dis Sci 2006;51:370-3.
5. Chakrabarti P, Zullo A, Hassan C, Pandit A, Chowdhury A, Santra A, et al. Helicobacter pylori, gastric juice, and arterial ammonia levels in patients with cirrhosis. J Clin Gastroenterol 2002;34:578-81.
6. Dasani BM, Sigal SH, Lieber CS. Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection. Am J Gastroenterol 1998;93:726-31.
7. Miyaji H, Ito S, Azuma T, Ito Y, Yamazaki Y, Ohtaki Y, et al. Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis. Gut 1997;40:726-30.
8. Chen SJ, Wang LJ, Zhu Q, Cai JT, Chen T, Si JM. Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients. World J Gastroenterol 2008; 14:1914-8.
9. Abdel-Hady H, Zaki A, Badra G, Lotfy M, Selmi C, Giorgini A, et al. Helicobacter pylori infection in hepatic encephalopathy: relationship to plasma endotoxins and blood ammonia. Hepatol Res 2007;37:1026-33.
10. Vásconez C, Elizalde JI, Llach J, Ginès A, de la Rosa C, Fernán dez RM, et al. Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication. J Hepatol 1999;30:260-4.
11. Zullo A, Hassan C, Morini S. Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions. Dig Liver Dis 2003; 35:197-205.
12. Zullo A, Rinaldi V, Efrati C, Hassan C, Caroli S, Riggio O, et al. Zinc, ammonia, and Helicobacter pylori infection in liver cirrhosis. Dig Liver Dis 2000;32:836-8.
13. Miquel J, Barcena R, Boixeda D, Fernández J, SanRoman AL, Martín-de-Argila C, et al. Role of Helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy. Eur J Gastroenterol Hepatol 2001;13:1067-72.
14. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
15. Group CEPaOoC. EPOC resources for review authors. [accessed on 2011 July 5]. Available at: http://epoc.cochrane.org/epoc-resources.
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
17. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. 2008. The Cochrane Callaboration. Available at: http://www.cochrane-handbook.org.
18. Normand SL. Meta-analysis: formulating, evaluating, combining, and reporting. Stat Med 1999;18:321-59.
19. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
20. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
21. Kini D, Aggarwal R, Saraswat VA, Naik SR. Role of Helicobacter pylori infection in hyperammonemia and subclinical hepatic encephalopathy in cirrhosis of liver. Indian J Gastroenterol 2001;20: 237-40.
22. Yang CS, Cao SY, He XJ, Wang YX, Zhang YL. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2007;19:422-4.
23. Dunn BE, Campbell GP, Perez-Perez GI, Blaser MJ. Purification and characterization of urease from Helicobacter pylori. J Biol Chem 1990;265:9464-9.
24. Turbett GR, Nandapalan N, Campbell IG, Nikoletti SM, Mee BJ. Characterisation of the urease from Helicobacter pylori and comparison with the ureases from related spiral gastric bacteria. FEMS Microbiol Immunol 1991;3:19-24.
25. Neithercut WD, Rowe PA, el Nujumi AM, Dahill S, McColl KE. Effect of Helicobacter pylori infection on intragastric urea and ammonium concentrations in patients with chronic renal failure. J Clin Pathol 1993;46:544-7.
26. Evans WB, Aoyagi T, Summerskill WH. Gastrointestinal urease in man. II. Urea hydrolysis and ammonia absorption in upper and lower gut lumen and the effect of neomycin. Gut 1966;7:635-9.
27. Conn HO. Studies of the source and significance of blood ammonia. IV. Early ammonia peaks after ingestion of ammonium salts. Yale J Biol Med 1972;45:543-9.
28. Rudman D, DiFulco TJ, Galambos JT, Smith RB 3rd, Salam AA, Warren WD. Maximal rates of excretion and synthesis of urea in normal and cirrhotic subjects. J Clin Invest 1973;52:2241-9.
29. Huber M, Rössle M, Siegerstetter V, Ochs A, Haag K, Kist M, et al. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Hepatogastroenterology 2001;48:541-4.
30. DuBois S, Eng S, Bhattacharya R, Rulyak S, Hubbard T, Putnam D, et al. Breath ammonia testing for diagnosis of hepatic encephalopathy. Dig Dis Sci 2005;50:1780-4.
31. Calvet X, Nogueras C, Roqué M, Sanfeliu I. Helicobacter pylori is not a risk factor for hepatic encephalopathy. Dig Liver Dis 2001;33:414-9.
32. Webberley MJ, Webberley JM, Newell DG, Lowe P, Melikian V. Seroepidemiology of Helicobacter pylori infection in vegans and meat-eaters. Epidemiol Infect 1992;108:457-62.
33. Nardone G, Coscione P, D'Armiento FP, Del Pezzo M, Pontillo M, Mossetti G, et al. Cirrhosis negatively affects the efficiency of serologic diagnosis of Helicobacter pylori infection. Ital J Gastroenterol 1996;28:332-6.
34. Taylor-Robinson SD, Jackson N, Buckley C. Helicobacter pylori, ammonia and the brain. Gut 1997;40:805-6.
35. Johnston SC. Identifying confounding by indication through blinded prospective review. Am J Epidemiol 2001;154:276-84.